ClinicalTrials.Veeva

Menu

BOO and DU and Their Clinical and Urodynamic Findings in Women With ≥Stage II Cystocele

National Taiwan University logo

National Taiwan University

Status

Completed

Conditions

Bladder Outlet Obstruction and Detrusor Underactivity in Women With Severe Cystocele

Treatments

Diagnostic Test: Pad test

Study type

Observational

Funder types

Other

Identifiers

NCT03613324
201805025RINB

Details and patient eligibility

About

Prevalence rates of bladder outlet obstruction (BOO) and detrusor underactivity (DU) and their related clinical and urodynamic findings in women with ≥ pelvic organ prolapse quantification stage II cystocele are important for clinical consultation. Thus, the aim of this study was to elucidate the above findings and between-group associations.

Full description

Between November 2011 and January 2017, medical records of all women with ≥stage II cystocele who underwent 20 min pad testing and urodynamic studies in a medical center were reviewed. Only those with complete data of maximum flow rate (Qmax) and detrusor pressure at maximum flow rate (PdetQmax) were enrolled. ANOVA test and post-hoc testing with bonferroni's correction were used for statistical analysis. Woman were defined as having DU when Qmax was <12 mL/s and PdetQmax was <10 cmH2O, and were defined as having BOO when Qmax was <12 mL/s and PdetQmax was ≥25 cmH2O with sustained detrusor contraction during voiding cystometry.

Enrollment

455 patients

Sex

Female

Ages

20+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Age > 20y/o
  2. Cystocele > stage II
  3. Complete pad test and urodynamic study

Exclusion criteria

  1. Pregnancy
  2. Urinary tract infection
  3. Had received pelvic reconstruction surgery

Trial design

455 participants in 3 patient groups

Bladder outlet obstruction (BOO)
Description:
Between November 2011 and January 2017, medical records of all women with ≥stage II cystocele who underwent 20 min pad testing and urodynamic studies in a medical center were reviewed. Woman were defined as having BOO when Qmax was \<12 mL/s and PdetQmax was ≥25 cmH2O with sustained detrusor contraction during voiding cystometry.
Treatment:
Diagnostic Test: Pad test
Detrusor underactivity (DU)
Description:
Between November 2011 and January 2017, medical records of all women with ≥stage II cystocele who underwent 20 min pad testing and urodynamic studies in a medical center were reviewed. Woman were defined as having DU when Qmax was \<12 mL/s and PdetQmax was \<10 cmH2O during voiding cystometry.
Treatment:
Diagnostic Test: Pad test
ND BOO/DU
Description:
Between November 2011 and January 2017, medical records of all women with ≥stage II cystocele who underwent 20 min pad testing and urodynamic studies in a medical center were reviewed. This group revealed no demonstrated bladder outlet obstruction nor detrusor underactivity.
Treatment:
Diagnostic Test: Pad test

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems